Skip to main content
SpringerLink
Log in
Book cover

Radiofrequency Ablation for Small Hepatocellular Carcinoma pp 11–24Cite as

Pathobiologic Characteristics of Small Hepatocellular Carcinoma

  • Chapter
  • First Online:

  • 696 Accesses

Abstract

Early diagnosis and treatment of cancer have long been established as basic principles of modern surgical oncology. There is no doubt that a better understanding of the pathobiological features of small hepatocellular carcinoma (SHCC) will provide clinicians with the pathobiological basis to better treat these tumors and to improve long-term survivals of patients. For relatively small HCC, several designations such as “early HCC” and “subclinical HCC” [1] have been proposed. The definitions of these tumors are based mainly upon tumor size, and each definition uses a different size. The concept of SHCC can be traced back to the late 1970s [2, 3], when SHCC was considered as the most significant prognostic factor of long-term survival.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Tang ZY. Subclinical hepatocellular carcinoma: Historical aspects and general consideration. In: Tang ZY, editor. Subclinical hepatocellular carcinoma. Berlin: Springer; 1985. p. 1–11.

    Google Scholar 

  2. Zhaoyou T, Yeqin Y, Zhiying L, et al. Small hepatocellular carcinoma: clinical analysis of 30 cases. Chin Med J (Engl). 1979;92(7):455–62.

    CAS  Google Scholar 

  3. Wu MC, Chen H, Zhang XH, et al. Primary hepatic carcinoma resection over 18 years. Chin Med J (Engl). 1980;93(10):723–8.

    CAS  Google Scholar 

  4. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38.

    Article  CAS  PubMed  Google Scholar 

  5. Okuda K, Nakashima T, Obata H, et al. Clinicopathological studies of minute hepatocellular carcinoma. Analysis of 20 cases, including 4 with hepatic resection. Gastroenterology. 1977;73(1):109–15.

    CAS  PubMed  Google Scholar 

  6. Kanematsu T, Sonoda T, Takenaka K, et al. The value of ultrasound in the diagnosis and treatment of small hepatocellular carcinoma. Br J Surg. 1985;72(1):23–5.

    Article  CAS  PubMed  Google Scholar 

  7. Kondo Y, Niwa Y, Akikusa B, et al. A histopathologic study of early hepatocellular carcinoma. Cancer. 1983;52(4):687–92.

    Article  CAS  PubMed  Google Scholar 

  8. Cong WM, Wu MC. The biopathologic characteristics of DNA content of hepatocellular carcinomas. Cancer. 1990;66(3):498–501.

    Article  CAS  PubMed  Google Scholar 

  9. Libbrecht L, Severi T, Cassiman D, et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol. 2006;30(11):1405–11.

    Article  PubMed  Google Scholar 

  10. Aishima S, Nishihara Y, Kuroda Y, et al. Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma. Am J Surg Pathol. 2007;31(5):783–91.

    Article  PubMed  Google Scholar 

  11. Okuwaki Y, Nakazawa T, Shibuya A, et al. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol. 2008;43(1):71–8.

    Article  PubMed  Google Scholar 

  12. Kudo M. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity. Intervirology. 2004;47(3-5):227–37.

    Article  PubMed  Google Scholar 

  13. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000;32(6):1224–9.

    Article  CAS  PubMed  Google Scholar 

  14. Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002;20(6):1527–36.

    Article  PubMed  Google Scholar 

  15. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47(1):97–104.

    Article  PubMed  Google Scholar 

  16. Farinati F, Sergio A, Baldan A, et al. Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study. BMC Cancer. 2009;9:33.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cong W, Wu M, Wang Y, et al. Primary liver tumors in China. Oncol Rep. 1997;4(3):649–52.

    CAS  PubMed  Google Scholar 

  18. Lu XY, Xi T, Lau WY, et al. Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. J Cancer Res Clin Oncol. 2011;137(4):567–75.

    Article  PubMed  Google Scholar 

  19. Cong WM. Clinicopathologic features of small hepatocellular carcinoma – an analysis of ninety-three cases. Zhonghua Zhong Liu Za Zhi. 1993;15(5):372–4.

    CAS  PubMed  Google Scholar 

  20. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11(9):1086–92.

    Article  PubMed  Google Scholar 

  21. LCSGO. Classification of primary liver cancer. Tokyo: Kanehara Press Co; 1997.

    Google Scholar 

  22. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178(2):493–7.

    Article  CAS  PubMed  Google Scholar 

  23. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–9.

    Article  CAS  PubMed  Google Scholar 

  24. Nathan H, Hyder O, Mayo SC, et al. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis. Ann Surg. 2013;258(6):1022–7.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998;27(6):1572–7.

    Article  CAS  PubMed  Google Scholar 

  26. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30(6):1434–40.

    Article  CAS  PubMed  Google Scholar 

  27. Llovet JM, Chen Y, Wurmbach E, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology. 2006;131(6):1758–67.

    Article  CAS  PubMed  Google Scholar 

  28. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907–17.

    Article  PubMed  Google Scholar 

  29. Sakamoto M, Hirohashi S. Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection. Jpn J Clin Oncol. 1998;28(10):604–8.

    Article  CAS  PubMed  Google Scholar 

  30. Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology. 1998;28(5):1241–6.

    Article  CAS  PubMed  Google Scholar 

  31. Bruix J, Sherman M. Practice Guidelines Committee AaFTSOLD. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–36.

    Article  PubMed  Google Scholar 

  32. Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sakamoto M. Pathology of early hepatocellular carcinoma. Hepatol Res. 2007;37 Suppl 2:S135–8.

    Article  PubMed  Google Scholar 

  34. Sakamoto M. Early HCC: diagnosis and molecular markers. J Gastroenterol. 2009;44 Suppl 19:108–11.

    Article  CAS  PubMed  Google Scholar 

  35. Kim SJ, Lee KK, Kim DG. Tumor size predicts the biological behavior and influence of operative modalities in hepatocellular carcinoma. Hepatogastroenterology. 2010;57(97):121–6.

    PubMed  Google Scholar 

  36. Cong Wm WM. Significance of clinicopathology in quantitative measurement of DNA content in hepatocellular carcinoma. J Med Coll PLA. 1988;3:153–6.

    Google Scholar 

  37. Ng IO, Lai EC, Ho JC, et al. Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma. Am J Clin Pathol. 1994;102(1):80–6.

    Article  CAS  PubMed  Google Scholar 

  38. Kojiro M, Wanless IR, Alves V, et al. International Consensus Group for Hepatocellular Neoplasiathe International Consensus Group for Hepatocellular N. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology. 2009;49(2):658–64.

    Google Scholar 

  39. Llovet JM, Fuster J, Bruix J, et al. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10(2 Suppl 1):S115–20.

    Article  PubMed  Google Scholar 

  40. Tsuda H, Hirohashi S, Shimosato Y, et al. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology. 1988;95(6):1664–6.

    Article  CAS  PubMed  Google Scholar 

  41. Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 1990;336(8724):1150–3.

    Article  CAS  PubMed  Google Scholar 

  42. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991;22(2):172–8.

    Article  CAS  PubMed  Google Scholar 

  43. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211(3):277–87.

    Google Scholar 

  44. Livraghi T, Bolondi L, Buscarini L, et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol. 1995;22(5):522–6.

    Article  CAS  PubMed  Google Scholar 

  45. Ryder SD, British Society of Group. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52(3):1–8.

    Google Scholar 

  46. Forner A, Hessheimer AJ, Isabel Real M, et al. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol. 2006;60(2):89–98.

    Article  PubMed  Google Scholar 

  47. Edge SB, Byrd DR, Carducci MA. American Joint Committee on Cancer (AJCC) Cancer staging manual. New York: Springer; 2009.

    Google Scholar 

  48. Kunavisarut T, Kak I, Macmillan C, et al. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma. BMC Cancer. 2012;12:523.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Edge SB, Byrd DR, Compton CC. AJCC Cancer staging manual. New York: Springer; 2010. p. 347–76.

    Google Scholar 

  50. Laudano MA, Klafter FE, Katz M, et al. Pathological tumour diameter predicts risk of conventional subtype in small renal cortical tumours. BJU Int. 2008;102(10):1385–8.

    PubMed  Google Scholar 

  51. Saito H, Osaki T, Murakami D, et al. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg. 2006;192(3):296–300.

    Article  PubMed  Google Scholar 

  52. Zy T. Primary liver cancer. Shanghai: Shanghai Scientific & Technical Publishers; 1981.

    Google Scholar 

  53. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology. 1986;90(2):289–98.

    Article  CAS  PubMed  Google Scholar 

  54. Kanai T, Hirohashi S, Upton MP, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer. 1987;60(4):810–9.

    Article  CAS  PubMed  Google Scholar 

  55. Cong WM. Clinical studies on pathobiological characteristics of early hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi. 1991;29(6):341–4, 396.

    CAS  PubMed  Google Scholar 

  56. Moribe T, Iizuka N, Miura T, et al. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int J Cancer. 2009;125(2):388–97.

    Article  CAS  PubMed  Google Scholar 

  57. Kojiro M. ‘Nodule-in-nodule’ appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiation. Intervirology. 2004;47(3–5):179–83.

    Article  PubMed  Google Scholar 

  58. Lam VW, Ng KK, Chok KS, et al. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 2008;15(3):782–90.

    Article  PubMed  Google Scholar 

  59. Ueno S, Kubo F, Sakoda M, et al. Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg. 2008;15(5):493–500.

    Article  PubMed  Google Scholar 

  60. Vilana R, Bruix J, Bru C, et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology. 1992;16(2):353–7.

    Article  CAS  PubMed  Google Scholar 

  61. Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis. 1999;19(3):287–96.

    Article  CAS  PubMed  Google Scholar 

  62. Shimada M, Rikimaru T, Hamatsu T, et al. The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg. 2001;182(2):177–82.

    Article  CAS  PubMed  Google Scholar 

  63. Hu RH, Lee PH, Chang YC, et al. Prognostic factors for hepatocellular carcinoma < or = 3 cm in diameter. Hepatogastroenterology. 2003;50(54):2043–8.

    PubMed  Google Scholar 

  64. Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg. 2004;198(3):356–65.

    Article  PubMed  Google Scholar 

  65. Wu FS, Zhao WH, Liang TB, et al. Survival factors after resection of small hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2005;4(3):379–84.

    PubMed  Google Scholar 

  66. Marelli L, Grasso A, Pleguezuelo M, et al. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score. Ann Surg Oncol. 2008;15(12):3503–11.

    Article  CAS  PubMed  Google Scholar 

  67. Cancer CSOL. Clinical diagnosis and staging of primary liver cancer. Chin J Hepatol. 2001;9:324.

    Google Scholar 

  68. Kudo M, Izumi N, Kokudo N, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29(3):339–64.

    Article  PubMed  Google Scholar 

  69. Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2011;98(9):1210–24.

    Article  CAS  PubMed  Google Scholar 

  70. Cabrera R, Nelson DR. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther. 2010;31(4):461–76.

    Article  CAS  PubMed  Google Scholar 

  71. Memon K, Kulik L, Lewandowski RJ, et al. Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology. 2011;141(2):526–35, 535 e521-522.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Hermanek P, Sobin LH. TNM classification of malignant tumours. Berlin: Springer; 1987.

    Book  Google Scholar 

  73. Sobin LH, Wittekind C. TNM classification of malignant tumours. New York: Wiley-Liss; 1997.

    Google Scholar 

  74. Izumi R, Shimizu K, Ii T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994;106(3):720–7.

    Article  CAS  PubMed  Google Scholar 

  75. Staudacher C, Chiappa A, Biella F, et al. Validation of the modified TNM-Izumi classification for hepatocellular carcinoma. Tumori. 2000;86(1):8–11.

    CAS  PubMed  Google Scholar 

  76. Chiappa A, Zbar AP, Podda M, et al. Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection. Hepatogastroenterology. 2001;48(37):229–34.

    CAS  PubMed  Google Scholar 

  77. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003;38(3):207–15.

    Article  PubMed  Google Scholar 

  78. Kondo F, Hirooka N, Wada K, et al. Morphological clues for the diagnosis of small hepatocellular carcinomas. Virchows Arch A Pathol Anat Histopathol. 1987;411(1):15–21.

    Article  CAS  PubMed  Google Scholar 

  79. Nagao T, Nagashima I, Inoue S, et al. Hepatic resection for minute hepatocellular carcinoma. Surg Today. 1992;22(2):110–4.

    Article  CAS  PubMed  Google Scholar 

  80. Nakashima O, Sugihara S, Kage M, et al. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. Hepatology. 1995;22(1):101–5.

    CAS  PubMed  Google Scholar 

  81. Ikai I, Arii S, Kojiro M, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101(4):796–802.

    Article  PubMed  Google Scholar 

  82. Ando E, Kuromatsu R, Tanaka M, et al. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol. 2006;40(10):942–8.

    Article  PubMed  Google Scholar 

  83. Minagawa M, Ikai I, Matsuyama Y, et al. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245(6):909–22.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47(1):82–9.

    Article  PubMed  Google Scholar 

  85. Takayama T, Makuuchi M, Hasegawa K. Single HCC smaller than 2 cm: surgery or ablation?: surgeon’s perspective. J Hepatobiliary Pancreat Sci. 2010;17(4):422–4.

    Article  PubMed  Google Scholar 

  86. Di Tommaso L, Destro A, Fabbris V, et al. Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma. Hepatology. 2011;53(5):1549–57.

    Article  PubMed  CAS  Google Scholar 

  87. Yamashita Y, Tsuijita E, Takeishi K, et al. Predictors for microinvasion of small hepatocellular carcinoma </= 2 cm. Ann Surg Oncol. 2012;19(6):2027–34.

    Article  PubMed  Google Scholar 

  88. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl. 2004;10(2 Suppl 1):S3–8.

    Article  PubMed  Google Scholar 

  89. Nakashima Y, Nakashima O, Tanaka M, et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res. 2003;26(2):142–7.

    Article  PubMed  Google Scholar 

  90. Sasaki Y, Imaoka S, Ishiguro S, et al. Clinical features of small hepatocellular carcinomas as assessed by histologic grades. Surgery. 1996;119(3):252–60.

    Article  CAS  PubMed  Google Scholar 

  91. Desmet VJ. East-West pathology agreement on precancerous liver lesions and early hepatocellular carcinoma. Hepatology. 2009;49(2):355–7.

    Article  PubMed  Google Scholar 

  92. Kondo F. Histological features of early hepatocellular carcinomas and their developmental process: for daily practical clinical application : Hepatocellular carcinoma. Hepatol Int. 2009;3(1):283–93.

    Article  PubMed  Google Scholar 

  93. Park YN. Update on precursor and early lesions of hepatocellular carcinomas. Arch Pathol Lab Med. 2011;135(6):704–15.

    PubMed  Google Scholar 

  94. Di Tommaso L, Sangiovanni A, Borzio M, et al. Advanced precancerous lesions in the liver. Best Pract Res Clin Gastroenterol. 2013;27(2):269–84.

    Article  PubMed  Google Scholar 

  95. Kojiro M. Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West. Hepatol Res. 2007;37 Suppl 2:S121–4.

    Article  PubMed  Google Scholar 

  96. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005;42(1):27–34.

    Article  PubMed  Google Scholar 

  97. Henderson JM, Sherman M, Tavill A, et al. AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford). 2003;5(4):243–50.

    Article  CAS  Google Scholar 

  98. Lu W, Dong J, Huang Z, et al. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP TNM and CUPI. J Gastroenterol Hepatol. 2008;23(12):1874–8.

    Article  PubMed  Google Scholar 

  99. Greene F, Fleming I, Fritz A, et al. AJCC cancer staging manual. Chicago: Springer, 2010. p 435.

    Google Scholar 

  100. Forner A, Reig ME, De Lope CR, et al. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61–74.

    Article  CAS  PubMed  Google Scholar 

  101. Cong WM, Wu MC. Small hepatocellular carcinoma-current and future approaches. Hepatol Int. 2013;7(3):805–12.

    Article  PubMed  Google Scholar 

  102. Shiina S, Teratani T, Obi S, et al. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology. 2002;62 Suppl 1:64–8.

    Article  CAS  PubMed  Google Scholar 

  103. Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol. 2004;39(11):689–97.

    Article  PubMed  Google Scholar 

  104. Masayoshi T, Wakui N, Sumino Y. Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols. Exp Ther Med. 2012;4(6):959–61.

    PubMed  PubMed Central  Google Scholar 

  105. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol. 1996;167(3):759–68.

    Article  CAS  PubMed  Google Scholar 

  106. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–51.

    Article  PubMed  Google Scholar 

  107. Imai K, Beppu T, Chikamoto A, et al. Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less. Hepatol Res. 2013;43(8):853–64.

    Article  PubMed  Google Scholar 

  108. Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results. Eur J Surg Oncol. 2010;36(11):1054–60.

    Article  PubMed  Google Scholar 

  109. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17(3):684–92.

    Article  PubMed  Google Scholar 

  110. Ziol M, Sutton A, Calderaro J, et al. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. J Hepatol. 2013;59(6):1264–70.

    Article  CAS  PubMed  Google Scholar 

  111. Xia F, Lai EC, Lau WY, et al. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma. Ann Surg Oncol. 2012;19(4):1284–91.

    Article  PubMed  Google Scholar 

  112. Toshikuni N, Takuma Y, Goto T, et al. Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation. Hepatogastroenterology. 2012;59(120):2361–6.

    PubMed  Google Scholar 

  113. Dan J, Zhang Y, Peng Z, et al. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PLoS One. 2013;8(3), e58184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

    Wenming Cong MD, PhD & Xinyuan Lu MD

  2. The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China

    Wanyee Lau MD, DSc, FACS, FRCS, FRACS(Hon)

Authors
  1. Wenming Cong MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xinyuan Lu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wanyee Lau MD, DSc, FACS, FRCS, FRACS(Hon)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wenming Cong MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center Department of Hepatobiliary Surgery, Guangzhou, China

    Minshan Chen

  2. Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center Department of Hepatobiliary Surgery, Guangzhou, China

    Yaojun Zhang

  3. Prince of Wales Hospital, Chinese University of Hong Kong Prince of Wales Hospital, Hong Kong, China

    W.Y. Lau

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Cong, W., Lu, X., Lau, W. (2016). Pathobiologic Characteristics of Small Hepatocellular Carcinoma. In: Chen, M., Zhang, Y., Lau, W. (eds) Radiofrequency Ablation for Small Hepatocellular Carcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7258-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-7258-7_2

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-7257-0

  • Online ISBN: 978-94-017-7258-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation